Japanese Pharmaceutical Firms: Players in the European Market?

Jocelyn Probert

Chapter 14 in The Global Competitiveness of the Asian Firm, 1994, pp 232-264 from Palgrave Macmillan

Abstract: Abstract The pharmaceuticals sector ranks among the very few segments of Japanese industry that has yet to make a major mark on the international scene. Competitive advantages which other industries in Japan, such as cars and consumer electronics, have successfully exploited — namely incremental advances in development and production technology, productivity, low-cost manufacturing — are rather less relevant to the development of the pharmaceutical industry. The very structure of the industry mitigates against such competitive advantages: producer firms supply customers but are paid by a third party (the government), creating an insensitivity to price in the demand for drugs which, in turn, all but eliminates corporate considerations of cost and productivity.

Keywords: Foreign Firm; Drug Price; Home Market; Japanese Firm; Sales Force (search for similar items in EconPapers)
Date: 1994
References: Add references at CitEc
Citations: View citations in EconPapers (1)

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-1-349-23423-3_14

Ordering information: This item can be ordered from
http://www.palgrave.com/9781349234233

DOI: 10.1007/978-1-349-23423-3_14

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().